FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients


Aug 28 (Reuters) - Gilead Inc GILD.O said on Friday the U.S. Food and Drug Administration has authorized expanded emergency use for its experimental antiviral COVID-19 treatment, remdesivir.

The drug can now be used to treat all hospitalized patients with COVID-19, in addition to patients with a severe form of the illness. (

(Reporting By Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)

((; within U.S. +1 646 223 8780, outside U.S. +91 806749 8325;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.